Shahnawaz Imam, PhD

Who We Are

We’re a diverse group of academic physicians, scientists, engineers and entrepreneurs with groundbreaking biotechnology designed to transform treatments into cures.  At AdopTracell, we have come up with a biomolecular platform that utilizes naturally occurring, disease associated antibodies and tailors them to guide anti-inflammatory adoptive cellular therapies to the affected target organ-cell.